response

(redirected from PSA response)
Also found in: Dictionary, Thesaurus, Medical, Legal.

response

1. Bridge a bid replying to a partner's bid or double
2. Christianity a short sentence or phrase recited or sung by the choir or congregation in reply to the officiant at a church service
3. Electronics the ratio of the output to the input level, at a particular frequency, of a transmission line or electrical device
4. any pattern of glandular, muscular, or electrical reactions that arises from stimulation of the nervous system

response

[ri′späns]
(communications)
(control systems)
A quantitative expression of the output of a device or system as a function of the input. Also known as system response.
(statistics)
The value of some measurable quantity after a treatment has been applied.
References in periodicals archive ?
The higher dose of cabazitaxel did result in a higher PSA response rate (42.
Thus the percentage of PSA responses was not significantly different (.
1,2) In a recent review, Punnen et al concluded that salvage RT can provide durable PSA responses in a sizeable percentage of men, especially when given early (i.
These Phase 1 galeterone data, demonstrating minimal toxicities, improved PSA response and a reduction in tumor size, are exciting for those of us in the medical community treating this life-threatening cancer.
Only in Canada, efficacy data based on PSA response and QoL data were collected and evaluated based on prior abiraterone use.
The reported duration of disease stabilization ranged from 3-27 months, and the median duration of PSA response was 12 months, (range 2-21 months).
On the opposite side of the coin, however, a quarter of individuals experienced improvements in their pain, and overall, approximately 40% had a PSA response that was not affected by prior abiraterone exposure.
The study will also evaluate PSA response and the patient's return to urinary function baseline as well as normal lifestyle activities.
0001), confirmed PSA response rate defined as > 50% reduction in PSA from the pre-treatment baseline PSA (29% vs.
PSA response was defined as a decrease in PSA value of [less than or equal to]50% from pre-abiraterone PSA.
Secondary objectives include assessment of efficacy, as shown by PSA response and reduction of hormone levels.